Produkty 19764-35-3

CAS 19764-35-3 to numer rejestracyjny substancji Triandrin. Oferty producentów: GLPBio. Dostępne opakowania: 5mg.

Triandrin
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 3176,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[3-(4-hydroxyphenyl)prop-2-enoxy]oxane-3,4,5-triol (CAS 19764-35-3) to związek chemiczny o wzorze sumarycznym C15H20O7 i masie molowej 312.31 g/mol. Nazwa systematyczna IUPAC: (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[3-(4-hydroxyphenyl)prop-2-enoxy]oxane-3,4,5-triol. InChIKey: CNNXMGXBAZQZDE-UXXRCYHCSA-N.

Dane identyfikacyjne
Wzór sumarycznyC15H20O7
Masa molowa312.31 g/mol
Nazwa IUPAC(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[3-(4-hydroxyphenyl)prop-2-enoxy]oxane-3,4,5-triol
InChIKeyCNNXMGXBAZQZDE-UXXRCYHCSA-N
SMILESC1=CC(=CC=C1C=CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Triandrin, beta-D-Glucopyranoside, 3-(4-hydroxyphenyl)-2-propen-1-yl, |A-D-Glucopyranoside, 3-(4-hydroxyphenyl)-2-propen-1-yl, 3-(4-Hydroxyphenyl)prop-2-en-1-yl beta-D-glucopyranoside
Powiązane formy tego związku
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoxy]oxane-3,4,5-triol C15H20O7
Izomery (ten sam wzór sumaryczny)
(1S,2R,3S,7R,9R,10R,11S,12S)-3,10,11-trihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one C15H20O7
tris(prop-2-enyl) 2-hydroxypropane-1,2,3-tricarboxylate C15H20O7
2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-triene-17-carboxylic acid C15H20O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]phenoxy]oxane-3,4,5-triol C15H20O7
3-phenylpropyl (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoate C15H20O7
18-hydroxy-2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-triene-17-carbaldehyde C15H20O7
(2R,4aR,6S,7R,8R,8aS)-6-methoxy-2-(4-methoxyphenyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol C15H20O7
(1'S,2S,2'R,3'S,7'R,9'R,10'R,11'S)-3',10',11'-trihydroxy-2'-(hydroxy(113C)methyl)-1',5'-di((113C)methyl)spiro[(2,3-13C2)oxirane-2,12'-8-oxatricyclo[7.2.1.02,7]dodec-5-ene]-4'-one C15H20O7
(1S,2R,3S,5R,6R,7R,8S,9R,12S)-2,8-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methylspiro[4,10-dioxatetracyclo[7.2.1.02,7.03,5]dodecane-6,2'-oxirane]-11-one C15H20O7
(2E,4E)-5-[(1S,3S,5R,8S)-3,8-dihydroxy-1,5-dimethyl-7-oxo-6-oxabicyclo[3.2.1]octan-8-yl]-3-(hydroxymethyl)penta-2,4-dienoic acid C15H20O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(5-hydroxy-2-prop-2-enylphenoxy)oxane-3,4,5-triol C15H20O7